2015
Wu E, Jensen IS , Cyr PL , Fan W, Mitchell M, Sulham K, Nathwani D. Use of oritavancin for the treatment of skin and soft tissue infections: A UK hospital budget impact analysis. ISPOR 20th Annual International Meeting, Philadelphia, PA, 2015.
Publication: Abstracts and Presentations
Jensen I , Halbert R, Giuseppe R, Naoshy S, Iqbal SU, Zhimin X, McSweeney P. 2015. A hospital budget impact model to evaluate plerixafor in stem cell mobilization: Impact of primary research and direct stakeholder engagement. Eur J Hosp Pharm 22(3):142–149; doi: 10.1136/ejhpharm-2014-000543 .
View Abstract
Publication: Manuscripts
Sacks NC , Burgess JF, Cabral HJ, McDonnell ME, Pizer SD. 2015. The effects of cost sharing on adherence to medications prescribed for concurrent use: Do definitions matter? J Manag Care Pharmacy 21(8):678–687; doi: 10.18553/jmcp.2015.21.8.678 .
View Abstract
Publication: Manuscripts
Sacks NC , Ash AS, Ghosh K, Rosen AK, Wong JB, Cutler DM, Rosen AB. 2015. Recent national trends in acute myocardial infarction hospitalizations in Medicare: Shrinking declines and growing disparities [Letter to the Editor]. Epidemiol 26(4):e46–47; doi: 10.1097/EDE.0000000000000298 .
View Abstract
Publication: Manuscripts
Sacks NC , Ash AS, Ghosh K, Rosen AK, Wong JB, Rosen AB. 2015. Trends in acute myocardial infarction hospitalizations: Are we seeing the whole picture? Am Heart J 170(6):1211-1219; doi: 10.1016/j.ahj.2015.09.009 .
View Abstract
Publication: Manuscripts
2014
Wu C, Fortier KJ, LaPensee K, Fan W, Mitchell M, Cyr PL , Jensen IS . A US hospital economic impact model for oritavancin in ABSSSI patients with risk of MRSA infections. Abstract PSS10 , ISPOR 17th Annual European Congress 2014.
View Abstract
Publication: Abstracts and Presentations
Jensen IS , Bay C, Cyr PL . Estimating the impact of combining cangrelor and bivalirudin to a U.S. hospital performing PCI procedures. ISPOR 18th Annual International Meeting, New Montreal Quebec, 2014.
Publication: Abstracts and Presentations
Jensen IS , Wu C, Bay CB, Cyr PL . Estimating the clinical value of cangrelor in patients undergoing PCI. International Academy of Cardiology, 19th World Congress on Heart Disease, Boston, MA, 2014.
Publication: Abstracts and Presentations
Wu C, Fortier K, Fan WJ, LePensse K, Bay CB, Cyr PL , Jensen IS . A U.S. hospital budget impact model for oritivancin in ABSSSI patients with risk of MRSA infections. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
Publication: Abstracts and Presentations
Bay C, Cyr PL , Jensen IS . Estimating the value of cangrelor from eliminating preloading in coronary artery bypass graft (CABG) patients. ISPOR 16th Annual European Congress, Amsterdam, Netherlands, 2014.
A Division of